North America Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Country: Trend Forecast and Growth Opportunity

COVID-19
Get in-depth analysis of the COVID-19 impact on this
Market/Industry



North America biodefense market is expected to grow by 5.3% annually in the forecast period and reach $10.07 billion by 2030 amid the COVID-19 pandemic. Highlighted with 25 tables and 37 figures, this 103-page report “North America Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America biodefense market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America biodefense market in every aspect of the classification from perspectives of Product, Sales Channel, Application, and Country. Based on Product, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Vaccines • Anthrax • Smallpox • Botulism • Nuclear/Radiation • E-Bola • Zika • Other Vaccines Biothreat Detection Devices • Detectors/Triggering Devices • Assays and Reagents • Samplers • Identifiers Antibiotics Masks Other Products Based on Sales Channel, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Online Sales • Offline Sales Based on Application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Military • Civilian Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product, Sales Channel, and Application over the forecast years is also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in North America biodefense market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Achaogen, Inc. Alexeter Technologies LLC Alnylam Pharmaceuticals, Inc. Altimmune, Inc. Bavarian Nordic AS BioFactura, Inc. Cleveland Biolabs, Inc. Dynavax Technologies Inc Dynport Vaccine Company LLC (DVC) Elusys Therapeutics, Inc. Emergent BioSolutions Inc General Dynamics Corp. GlaxoSmithKline Plc Ichor Medical Systems Mediimmune (AstraZeneca) Nanotherapeutics, Inc. Ology Bioscience PathSensors Inc Pluristem Therapeutics Sanofi Pasteur Ltd. SIGA Technologies, Inc. Soligenix, Inc. Xoma Corporation (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)


1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 18
2.1 Market Size and Forecast 18
2.2 Major Growth Drivers 19
2.3 Market Restraints and Challenges 22
2.4 Emerging Opportunities and Market Trends 25
2.5 Porter’s Fiver Forces Analysis 29
3 Segmentation of North America Market by Product 33
3.1 Market Overview by Product 33
3.2 Vaccines 35
3.2.1 Anthrax 38
3.2.2 Smallpox 39
3.2.3 Botulism 40
3.2.4 Nuclear/Radiation 41
3.2.5 E-Bola 42
3.2.6 Zika 43
3.2.7 Other Vaccines 44
3.3 Biothreat Detection Devices 45
3.4 Antibiotics 47
3.5 Masks 48
3.6 Other Products 49
4 Segmentation of North America Market by Sales Channel 50
4.1 Market Overview by Sales Channel 50
4.2 Online Sales 52
4.3 Offline Sales 53
5 Segmentation of North America Market by Application 54
5.1 Market Overview by Application 54
5.2 Military 56
5.3 Civilian 57
6 North America Market 2019-2030 by Country 58
6.1 Overview of North America Market 58
6.2 U.S. 61
6.3 Canada 65
6.4 Mexico 67
7 Competitive Landscape 69
7.1 Overview of Key Vendors 69
7.2 New Product Launch, Partnership, Investment, and M&A 72
7.3 Company Profiles 73
Achaogen, Inc. 73
Alexeter Technologies LLC 75
Alnylam Pharmaceuticals, Inc. 76
Altimmune, Inc. 77
Bavarian Nordic AS 78
BioFactura, Inc. 79
Cleveland Biolabs, Inc. 80
Dynavax Technologies Inc 81
Dynport Vaccine Company LLC (DVC) 82
Elusys Therapeutics, Inc. 83
Emergent BioSolutions Inc 84
General Dynamics Corp. 85
GlaxoSmithKline Plc 86
Ichor Medical Systems 87
Mediimmune (AstraZeneca) 88
Nanotherapeutics, Inc. 89
Ology Bioscience 90
PathSensors Inc 91
Pluristem Therapeutics 92
Sanofi Pasteur Ltd. 93
SIGA Technologies, Inc. 94
Soligenix, Inc. 95
Xoma Corporation 96
8 Investing in North America Market: Risk Assessment and Management 97
8.1 Risk Evaluation of North America Market 97
8.2 Critical Success Factors (CSFs) 100
Related Reports and Products 103


List of Tables:

Table 1.  Snapshot of North America Biodefense Market, 2019-2030 17
Table 2.  Main Product Trends and Market Opportunities in North America Biodefense Market 25
Table 3. North America Biodefense Market by Product, 2019-2030, $ mn 33
Table 4. North America Biodefense Market: Vaccines by Application, 2019-2030, $ mn 36
Table 5. List of Biodefense Vaccine Pipelines 37
Table 6. North America Biodefense Market: Vaccines Biothreat Detection Devices by Type, 2019-2030, $ mn 46
Table 7. North America Biodefense Market by Sales Channel, 2019-2030, $ mn 50
Table 8. North America Market by Application, 2019-2030, $ mn 54
Table 9. North America Biodefense Market by Country, 2019-2030, $ mn 59
Table 10. U.S. Biodefense Market by Product, 2019-2030, $ mn 63
Table 11. U.S. Biodefense Market by Sales Channel, 2019-2030, $ mn 63
Table 12. U.S. Biodefense Market by Application, 2019-2030, $ mn 63
Table 13. Canada Biodefense Market by Product, 2019-2030, $ mn 66
Table 14. Canada Biodefense Market by Sales Channel, 2019-2030, $ mn 66
Table 15. Canada Biodefense Market by Application, 2019-2030, $ mn 66
Table 16. Mexico Biodefense Market by Product, 2019-2030, $ mn 68
Table 17. Mexico Biodefense Market by Sales Channel, 2019-2030, $ mn 68
Table 18. Mexico Biodefense Market by Application, 2019-2030, $ mn 68
Table 19. Achaogen, Inc.: Company Snapshot 73
Table 20. Achaogen, Inc.: Business Segmentation 73
Table 21. Achaogen, Inc.: Product Portfolio 74
Table 22. Achaogen, Inc.: Revenue, 2016-2018, $ mn 74
Table 23. Achaogen, Inc.: Recent Developments 74
Table 24.  Risk Evaluation for Investing in North America Market, 2019-2030 98
Table 25. Critical Success Factors and Key Takeaways 101


Figure 1. Research Method Flow Chart 10
Figure 2. Breakdown of Primary Research 12
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 5. North America Biodefense Market, 2019-2030, $ mn 18
Figure 6. Primary Drivers and Impact Factors of North America Biodefense Market 19
Figure 7. Primary Restraints and Impact Factors of North America Biodefense Market 22
Figure 8. Investment Opportunity Analysis 26
Figure 9. Porter’s Fiver Forces Analysis of North America Biodefense Market 29
Figure 10. Breakdown of North America Biodefense Market by Product, 2019-2030, % of Sales Revenue 33
Figure 11. North America Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%) 34
Figure 12. North America Biodefense Market: Vaccines, 2019-2030, $ mn 35
Figure 13. North America Biodefense Market: Anthrax, 2019-2030, $ mn 38
Figure 14. North America Biodefense Market: Smallpox, 2019-2030, $ mn 39
Figure 15. North America Biodefense Market: Botulism, 2019-2030, $ mn 40
Figure 16. North America Biodefense Market: Nuclear/Radiation, 2019-2030, $ mn 41
Figure 17. North America Biodefense Market: E-Bola, 2019-2030, $ mn 42
Figure 18. North America Biodefense Market: Zika, 2019-2030, $ mn 43
Figure 19. North America Biodefense Market: Other Vaccines, 2019-2030, $ mn 44
Figure 20. North America Biodefense Market: Biothreat Detection Devices, 2019-2030, $ mn 45
Figure 21. North America Biodefense Market: Antibiotics, 2019-2030, $ mn 47
Figure 22. North America Biodefense Market: Masks, 2019-2030, $ mn 48
Figure 23. North America Biodefense Market: Other Products, 2019-2030, $ mn 49
Figure 24. Breakdown of North America Biodefense Market by Sales Channel, 2019-2030, % of Sales Revenue 50
Figure 25. North America Addressable Market Cap in 2020-2030 by Sales Channel, Value ($ mn) and Share (%) 51
Figure 26. North America Biodefense Market: Online Sales, 2019-2030, $ mn 52
Figure 27. North America Biodefense Market: Offline Sales, 2019-2030, $ mn 53
Figure 28. Breakdown of North America Market by Application, 2019-2030, % of Revenue 54
Figure 29. North America Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 55
Figure 30. North America Biodefense Market: Military, 2019-2030, $ mn 56
Figure 31. North America Biodefense Market: Civilian, 2019-2030, $ mn 57
Figure 32. Breakdown of North America Biodefense Market by Country, 2019 and 2030, % of Revenue 59
Figure 33. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 60
Figure 34. U.S. Biodefense Market, 2019-2030, $ mn 62
Figure 35. Canada Biodefense Market, 2019-2030, $ mn 65
Figure 36.  Biodefense Market in Mexico, 2015-2026, $ mn 67
Figure 37. Growth Stage of North America Biodefense Industry over the Forecast Period 69

Let our analyst help you with a customized solution for your market research needs

Select the license

Credit card Logo
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
Discount  Check Discount Question  Enquiry Before
   Purchase
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
fgfhfhfgf